Background and Objective: Magnetic Resonance Guided Focused Ultrasound (MRgFUS) for liver 6 tumour ablation is a challenging task due to motion caused by breathing and occlusion due the 7 ribcage between the transducer and the tumour. To overcome these challenges, a novel system for 8 liver tumour ablation during free breathing has been designed. 9
Introduction 1 Magnetic Resonance guided Focused Ultrasound (MRgFUS) is a technique enabling the monitoring of 2 the thermometry in real time while applying FUS. MRgFUS has been CE (Conformité Européene
System (TTS TRANS-FUSIMO, EU FP7 project) is a newly developed system with a dedicated software 8 to enable the application of MRgFUS in upper abdominal organs such as in liver. This novel software 9 is based on the mathematical models describing the motion due to breathing, the propagation of the 10 ultrasound waves through the rib cage and into the targeted tumour destination, and the multi-base 11 line algorithm to read the temperature during ablation [2] . Virtual reality simulations prove to be 12 promising in achieving an accurate prediction of a real patient scenario [3] . However, safety and 13 efficiency of the application still depend on the successful configuration of the hardware and the 14 efficient control of the process parameters [1] . For these reason, the most important process 15 parameters for successful ablation of liver tumour have been identified with pre-defined specs 16 based on the best known clinical practice by TRANSFUSIMO consortium [4] . These identified process 17 parameters are as follows; delivered acoustic power (with an efficiency of 70-90 %), actual 18 sonication duration (with less than 1 second of deviation), delay after an emergency stop (less than 19 200 ms), sonicating to a certain location (within 1 mm accuracy) and reaching to a desired 20 temperature (with less than 10% of deviation) [4] . Each of these parameters needs to be controlled 21 by the TTS software reliably. For this reason, it is important to design a protocol to measure the 22 deviations and provide evidence by providing supportive data for safety before clinical applications. 23
Due to the high level of energy delivery during treatment, the TTS software is classified as class 3/C 24 high risk software, where serious injury or death is possible according to the international standard 25 IEC 62304. For this reason, it is crucial to develop a reliable protocol following the requirements of 1 International Organisation for Standardization, ISO 13485 Quality Management System (QMS). This 2 is a mandatory step for CE marking approval for clinical use. The CE mark is a legal designation that a 3 medical product has met the requirements of all relevant Medical Device Directives in the EU. To 4 achieve this status, as a first step, effective and safe acoustic power delivery of this novel system was 5 cross validated against the best available clinical standard by applying a dedicated testing protocol in 6 compliance with ISO 13485 quality management system for medical device design [1] . Based on the 7 successful evaluation, the next step is to develop a methodology for the quantification of sonication 8 duration and the delay after the emergency stop. Quantifying sonication duration is important both 9 in static and dynamic application of the MRgFUS, however due to breathing motion, control of 10 sonication duration and being able to stop sonication in case of an emergency, is very crucial. In case 11 of a delay in an emergency stop, there is a risk of sonicating to vital structures, such as arteries or 12 sonicating to healthy tissues; instead of the targeted tumour tissue only. Sonicating less than the 13 planned duration might cause inefficient treatment, and can have adverse effects on the response of 14 autoimmune system [5] . In compliance with ISO 13485, a novel protocol is developed which 15 consisted of design and development plans, risk assessment forms, risk assessment matrices and 16 traceability matrices. This study differs from the other studies in literature [6] [7] [8] , as it aims to 17 translate science into a clinical application by following the requirements of quality management 18 systems from the beginning. Whereas, the other published work [5-9] only provides information on 19 quality assurance for the systems which already received clinical approvals, and these studies only 20 aim to provide guidance on reliable and safe use in clinics. Vicari et al. [8] also mentions the 21 importance of pre-clinical testing, however, their study only investigates the system efficiency in 22 pre-clinical settings with no reference to sonication duration verification. Although Bucknor et al. [9] 23 investigates the duration, they investigate the combined effect of power and sonication duration for 24 optimum clinical applications with a system which already received clinical approval. Obtaining a 25 clinical approval for a new methodology is a very challenging task and demands evidence for safety 26 and efficiency. For this reason, it is important to develop and design protocols for assessing each 1 process parameters individually. 2
Below the TTS is explained briefly and the current protocol is described in detail in the methodology 3 section. 4
Background 5
The evaluated version of the TTS is installed on a desktop PC. It communicates with the user 6 interface of Signa 1.5 T MR Scanner (GE Healthcare, Milwaukee, MN, USA) and the transducer of 7
Conformal Bone System 2100 (CBS) (Insightec Ltd, Tirat Carmel, Israel) as shown in Figure 1 . This 8 structure is similar to the structure of ExAblate 2100 TTS (Insightec Ltd, Tirat Carmel, Israel) 9 however, the system has a completely novel software controlling the transducer of the CBS. The 10 software itself is its first kind in ablating to a moving target; aiming at obtaining a CE mark status for 11 clinical applications for liver tumour applications. TTS has a user interface which provides 12 commands for operator to follow in using the MR scanner. TTS is synchronised with the MR scanner 13 by using the Transistor Transistor Logic (TTL) pulse. The system can deliver the electrical power and 14 convert it to the acoustic power within 70-90 % efficiency [1]. The developed power delivery 15 assessment protocol proves to be repeatable and applicable for power measurements. However, 16 there is still a need for robust, repeatable protocol for quantifying the duration of sonication and the 17 delay after emergency stop both for CE marking purposes and for routine maintenance of the 18 system in clinical settings. 19
High-level description of hard-and software components of the TTS 2
Methodology 3

Design considerations. 4
A special attention was paid to design a simple protocol which is well documented for all the steps to 5 be repeatable by any other operator to measure the actual sonication duration and its deviation 6 from the planned duration, as well as the delay after the emergency stop. The system configuration 7 and the devices were optimised for its simplicity for the purpose. Risk assessment was conducted to 8 eliminate any hardware related failure due to cabling, and any false positives and negatives due to 9 experimental errors. A code was written in LabVIEW for data accusation to synchronise the time of 10 the sonication command of TTS and the time of the data recording system. Specs were set as such 11 that the calculated average standard deviation of the sonication duration from the planned duration 12 should be less than 1 seconds and the delay should be less than 200 ms for system to be considered 13 as successful. 14 In this study, sonications were planned for 10 seconds, while sonicating with 50W,100W, and 150W 15 power levels for thirty times by two independent operators to measure the sonication duration. 16 100W sonications were stopped arbitrarily to simulate emergency stops to measure the delay via the 1 designed protocol; providing evidence for reliability and safe usage of TTS in clinical trials. Student's 2 T test is required to analyse the user dependency. Any data set producing deviation more than the 3 pre-defined specs needs to be reported and the system should not be used for clinical purpose until 4 it conforms to the specs. 5
Description of the system and the protocol 6
To collect data during sonication, fiber-optic hydrophone (Pa Ltd, Dorset, UK) was used. The fiber-7 optic hydrophone works on the principle of interferometric detection of changes in the optical thick-8 ness of a thin polymer film at the tip of the optical fiber sensor downlead [10] . The experiment set-up 9 consisted of a water tank filled with degassed water over which a gridded fibre-optic sensor holder 10 was placed (Figure2). The fibre-optic hydrophone sensor was mounted in a sensor holder (Figure 3a ) 11 and inserted into a 3D printed grid surface and used as a microphone for recording the sound infor-12 mation. The fibre-optic sensor was hard wired to fibre-optic hydrophone system control unit. The hydrophone 13 system was connected to a PicoScope, a device like an oscilloscope, which is programmed to provide monitoring 14 on a PC. Hydrophone was connected via the "AC out" connector on the front panel to the PicoScope (Picotech, 15 UK). PicoScope has two inputs, the first is the output of the hydrophone, and the second is the trigger pulse 16 coming from the TRANSFUSIMO Treatment Software. To initiate the recording of the data, the TTL pulse which 17 is generated by the TRANSFUSIMO Treatment system, was utilised. The TTL pulse time was treated as the origin 18 for recording procedure. The TTL box had a splitter to send the same signal to the MR from the TTS software to Before sonication starts, the operator activates the arm command, enabling the transducer to send 11 almost zero power sonication for a safety check for sonication to start in full power. The tag lines 12 are generated in the data log of TTS software, when the arm command is activated and for the time 13 information when the sonication ends. 14 Once the setup is tested for feasibility, experiments are executed for the planned sonication 15 duration of 10 seconds while applying sonication power levels of 50 W, 100W, and 150 W. To 16 produce a meaningful data set, experiments are planned to be repeated for 30 times by two 1 independent users. To eliminate long treatment planning and monitoring using MR step and for 2 regular quality assurance (QA) purposes, the TTS software has a Trans-Fusimo Execute Sonication 3 Application (TESA). With the recorded coordinate values after the first successful feasibility test, the 4 TESA application is used to eliminate MR monitoring and imaging time. This protocol enables 5 repeatability experiments to take place in shorter amount of time with a faster sonication 6 procedure. TESA requires only the magnitude of electrical power, the focal position, and the 7 duration of planned sonication as an input and does not use MR monitoring (Figure 3e) . 8
In the user interface of TESA application, pressing the 'Arm HIFU Transducer' button initialises the 9 transducer and makes it ready for instant sonication, i.e., the transducer is powered up and the 10 elements are configured to random phases with almost-zero output power. Once arming is 11 complete, the sonication is executed by pressing the 'Execute Sonication' button. where Δt3 is the length of the signal on PicoScope, Δt2 is the length of the sonication stop tag and 8
Δt1 is the execute sonication tag info in the log book of the TTS software. 9
The data files were extracted from the PicoScope in the form of CSV files for post processing. The x 10 axis to record the time value when reaching a peak value on the y axis is recorded at the start of 11 actual sonication data. The values of t1 and t2 were read from the excel files where the signal passed 12 the threshold noise signal level. The same also applies to calculation of delay for emergency stops. 13
The graphs are provided in the scale of seconds for demonstration purposes to cover the full signal 14 length in Figure4, however, the data is collected in the scale of milliseconds. Emergency stop signal with an arbitrary duration to measure the delay after stop button is pressed. 2
Results 3
Using the processed data, average duration and standard deviations were calculated for each soni-4 cation power value; 50 W, 100W, and 150W for 10 seconds and for each independent operator. For 5 emergency stops, the results show that the average emergency stop time delay is 14 ms (Std 0.16) by 6 the first operator and 13 ms (Std 0.14) by the second operator 2, meeting the specs set previously; 7 less than 200 ms. The two-paired T test show that the results do not have user dependency p>0,05. 8 9 Table 1 . Results for planned '10 second' sonication duration for (50, 100, and 150 W) of sonication 10 by two independent operators. 11 12 5. Discussions 13
